|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.55 USD | -4.24% |
|
-14.22% | -28.24% |
| 07-24 | Jefferies Cuts Summit Therapeutics Price Target to $15 From $17, Hold Rating Kept | MT |
| 07-24 | Summit Therapeutics Inc., Q2 2026 Earnings Call, Jul 23, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 10.01B | - | - | - | - | - |
| 55.01B | |||||
| 54.24B | |||||
| 23.38B | - | ||||
| 22.57B | - | ||||
| 20.19B |
Select your edition
All financial news and data tailored to specific country editions
